Literature DB >> 8428620

Functional expression of a MAP kinase kinase in COS cells and recognition by an anti-STE7/byr1 antibody.

C M Haystead1, J Wu, P Gregory, T W Sturgill, T A Haystead.   

Abstract

Mitogen-activated protein (MAP) kinases p42mapk and p44mapk are activated by dual tyrosine and threonine phosphorylation in vivo. Both MAPKs are phosphorylated and activated in vitro by an activator recently identified as a protein-tyrosine/threonine kinase. We have isolated a putative cDNA for a MAP kinase kinase (MAPKK) and determined its structure [Proc. Natl. Acad. Sci. USA, in press]. The protein encoded by this cDNA shares sequence homology with two yeast protein kinases byr1 and STE7. We now report that stimulation with serum of COS cells expressing this shares sequence homology with two yeast protein kinases byr1 and STE7. We now report that stimulation with serum of COS cells expressing this protein amplifies MAPK activator activity markedly. The increased activity co-migrates during chromatography with the expressed 45 kDa protein, recognized by an anti-STE7/byr1 antibody, and is abrogated by treatment with phosphatase 2A. Thus, this cDNA encodes a functional MAPKK. The anti-STE7/byr1 antibody also recognized a 46 kDa COS cell protein that was resolved from the expressed MAPKK by anion-exchange chromatography. This immunoreactive protein co-eluted with endogenous MAPKK activity, suggesting identification of the immunoreactive band as monkey MAPKK.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428620     DOI: 10.1016/0014-5793(93)81481-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2.

Authors:  J Wu; J K Harrison; P Dent; K R Lynch; M J Weber; T W Sturgill
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

2.  Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation.

Authors:  A J Rossomando; P Dent; T W Sturgill; D R Marshak
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

Review 3.  Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.

Authors:  Ufuk Degirmenci; Mei Wang; Jiancheng Hu
Journal:  Cells       Date:  2020-01-13       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.